Abatacept (powder) - HY-108829A
Nur noch %1 verfügbar
Catalog #
HY-108829A
Ab
496,00 €
Abatacept (CTLA4lg; BMS-188667) powder is a soluble fusion protein consisting of the extra-cellular domain of human CTLA4 and a fragment of the Fc portion of human IgG1 (hinge and CH2 and 3 domains). Abatacept powder is a selective T-cell co-stimulation modulator and a protein agent for the autoimmune diseases[1][2][3].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-108829A/Abatacept-powder-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Isolate blue ice and the product with bubble pack to avoid direct contact |
| Application | COVID-19-immunoregulation |
| Alternative Names | CTLA4lg (powder); BMS-188667 (powder) |
| CAS | 332348-12-6 |
| Storage | Store at 4°C for 2 years, do not freeze |
| MWT | N/A |
| Solubility | 10 mM in DMSO |
| Clinical Information | No Development Reported |
| Target | CTLA-4 |
| Application: | COVID-19-immunoregulation |
|---|